Mauriac syndrome in a 3-year-old boy. 2007

Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
Department of Pediatric Nephrology, Montefiore Medical Center, Bronx, New York, USA.

OBJECTIVE To report a case of Mauriac syndrome in a young child with poorly controlled type 1 diabetes mellitus. METHODS We describe the typical features of Mauriac syndrome and review the clinical, laboratory, and ultrasound findings and follow-up results in our current patient. RESULTS Hepatomegaly, growth impairment, and cushingoid features characterize Mauriac syndrome. Most frequently, it is seen in adolescents and young adults with a history of poor glycemic control. In our current patient, a 3-year-old boy with type 1 diabetes mellitus of 2 years' duration, Mauriac syndrome developed in the context of a disrupted social environment. His liver enzyme derangement, hepatomegaly, and growth improved once euglycemia was achieved. CONCLUSIONS Although Mauriac syndrome is currently uncommon, close monitoring of children with type 1 diabetes is important to maintain optimal glycemic control and prevent such an occurrence.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006529 Hepatomegaly Enlargement of the liver. Enlarged Liver,Liver, Enlarged
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D013577 Syndrome A characteristic symptom complex. Symptom Cluster,Cluster, Symptom,Clusters, Symptom,Symptom Clusters,Syndromes

Related Publications

Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
January 1983, American journal of nephrology,
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
May 1976, Pediatria polska,
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
June 1973, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
January 1992, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
July 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
September 1966, Wiadomosci lekarskie (Warsaw, Poland : 1960),
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
January 1966, Pediatria polska,
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
January 2007, Radiology case reports,
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
June 2012, Iranian journal of pediatrics,
Shefali Mahesh, and Robert J Karp, and Salvador Castells, and Jose Bernardo Q Quintos
January 1966, Archivio italiano di pediatria e puericoltura,
Copied contents to your clipboard!